PHSSR Policy Roadmaps for Acting Early on NCDs Synthesis Report 2025
Page 124 of 124 · WEF_PHSSR_Policy_Roadmaps_for_Acting_Early_on_NCDs_Synthesis_Report_2025.pdf
121 Acting early on NCDs
The Partnership for Health System Sustainability and ResilienceDomain 2: Governance
This domain assessed institutional arrangements and accountability mechanisms for NCD policy,
including:
Institutions : Roles and responsibilities of ministries, national committees, and regional authorities
in NCD policy development and implementation
Expertise and inclusivity : Involvement of professional bodies, patient organisations, and advocacy
groups in policy formation and decision-making processes
Data for policy formation : Availability and use of national health surveys, risk factor surveillance
systems, and evidence-based policy development processes
Strategy and targets : Existence, specificity, and implementation of national NCD strategies with
SMART targets for prevention, diagnosis, and treatment outcomes
Registries : Coverage, quality, and policy utility of disease-specific registries for cancer,
cardiovascular diseases, diabetes, and respiratory conditions
Crisis preparedness and response : Contingency plans for maintaining NCD services during health
system shocks, including lessons from COVID-19
Domain 3: Service delivery
This domain examined the organisation and delivery of NCD services across the care continuum:
Guidelines and protocols : Availability, quality, and implementation of evidence-based clinical
guidelines for NCD prevention, diagnosis, and management
Risk assessment : Use of validated risk stratification tools, biomarkers, polygenic risk scores, and
systematic identification of high-risk populations
Screening : Coverage and performance of organised screening programmes for cancer,
cardiovascular-metabolic conditions, kidney disease, and respiratory diseases
Diagnosis and referral : Efficiency of referral systems, diagnostic capacity, waiting times for imaging
and specialist assessment, and care coordination between levels
Secondary and tertiary prevention : Access to treatment following diagnosis, management of
multimorbidity, integrated care pathways, and monitoring for disease progression
Domain 4: Financing
This domain analysed financial arrangements affecting NCD prevention and care:
Health spending : Overall healthcare expenditure levels, prevention spending as proportion of health
budgets, and resource allocation across service types
Coverage and financial barriers : Gaps in public coverage for NCD services, out-of-pocket payments,
catastrophic health expenditure, and mechanisms for financial protection
Financial incentives : Provider payment methods, their alignment with prevention and coordinated
care objectives, and specific incentives for screening, early diagnosis, and quality improvement
Ask AI what this page says about a topic: